Center for Transplantation Sciences, Department of Surgery and.
Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
J Clin Invest. 2024 Jun 18;134(16):e179709. doi: 10.1172/JCI179709.
Tolerance of mouse kidney allografts arises in grafts that develop regulatory tertiary lymphoid organs (rTLOs). Single-cell RNA-seq (scRNA-seq) data and adoptive transfer of alloreactive T cells after transplantation showed that cytotoxic CD8+ T cells are reprogrammed within the accepted graft to an exhausted/regulatory-like phenotype mediated by IFN-γ. Establishment of rTLOs was required because adoptive transfer of alloreactive T cells prior to transplantation results in kidney allograft rejection. Despite the presence of intragraft CD8+ cells with a regulatory phenotype, they were not essential for the induction and maintenance of kidney allograft tolerance since renal allotransplantation into CD8-KO recipients resulted in acceptance and not rejection. Analysis of scRNA-seq data from allograft kidneys and malignant tumors identified similar regulatory-like cell types within the T cell clusters and trajectory analysis showed that cytotoxic CD8+ T cells are reprogrammed into an exhausted/regulatory-like phenotype intratumorally. Induction of cytotoxic CD8+ T cell dysfunction of infiltrating cells appears to be a beneficial mechanistic pathway that protects the kidney allotransplant from rejection through a process we call "defensive tolerance." This pathway has implications for our understanding of allotransplant tolerance and tumor resistance to host immunity.
在形成调节性三级淋巴器官 (rTLO) 的移植中,小鼠肾脏同种异体移植物的耐受性产生。单细胞 RNA 测序 (scRNA-seq) 数据和移植后同种反应性 T 细胞的过继转移表明,细胞毒性 CD8+T 细胞在接受的移植物内被重新编程为干扰素-γ介导的耗竭/调节样表型。rTLO 的建立是必需的,因为移植前同种反应性 T 细胞的过继转移会导致肾移植排斥。尽管同种异体移植物内存在具有调节表型的 CD8+细胞,但它们对于诱导和维持肾移植耐受不是必需的,因为肾同种异体移植到 CD8-KO 受体中会导致接受而不是排斥。对同种异体移植物肾脏和恶性肿瘤的 scRNA-seq 数据进行分析,在 T 细胞簇内鉴定出了类似的调节样细胞类型,轨迹分析表明,细胞毒性 CD8+T 细胞在肿瘤内被重新编程为耗竭/调节样表型。浸润细胞的细胞毒性 CD8+T 细胞功能障碍的诱导似乎是一种有益的机制途径,通过我们称之为“防御性耐受”的过程保护肾同种异体移植物免受排斥。该途径对于我们理解同种异体移植耐受和肿瘤对宿主免疫的抵抗具有重要意义。
Cochrane Database Syst Rev. 2024-12-19
J Clin Invest. 2024-8-15
J Clin Invest. 2025-5-13
Cochrane Database Syst Rev. 2013-12-2
Cochrane Database Syst Rev. 2013-11-27
Nat Biotechnol. 2024-2
Front Cell Dev Biol. 2022-12-8
J Transl Med. 2022-5-23
Life Sci Alliance. 2022-9
Science. 2022-1-7
Am J Transplant. 2022-3
Front Immunol. 2021